Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Efficacy of immune checkpoint inhibitors for gastrointestinal cancers with SWI/SNF complex genetic alterations.
Authors
Akinobu Nakata
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
Akinobu Nakata , Yukiya Narita , Ryosuke Kumanishi , Taiko Nakazawa , Takatsugu Ogata , Yuki Matsubara , Hiroyuki Kodama , Kazunori Honda , Toshiki Masuishi , Hiroya Taniguchi , Shigenori Kadowaki , Masashi Andoh , Rui Yamaguchi , Masahiro Tajika , Kei Muro
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.346
Abstract #
346
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2020 ASCO Virtual Scientific Program
Survival associated with mutations in SWI/SNF chromatin remodeling complex genes.
First Author: Michael J. Hassett
Poster
2020 ASCO Virtual Scientific Program
Genomic aberration of chromatin regulatory BAF complex as predictive biomarker for immunotherapy in gastrointestinal adenocarcinoma.
First Author: Changsong QI
Poster
2023 ASCO Annual Meeting
Phase 2 small cell lung cancer (SCLC) cohort of a phase 1b/2 trial of a liposomal formulation of eribulin in combination with nivolumab.
First Author: Koichi Azuma